First-in-class gene therapy targeting rare ischemic limb diseases with excellent market potential and no existing substitutes

CS Intelligent drug distributor with in-built functions. Planned to reduce human error in clinical trials and work together with VM a software solution aimed at automating clinical trials’ monitoring. Planned to replace the clinical trial Monitors’ physical visits at sites

New device for prostate biopsy designed to minimize risk of commonly occurring infections and complications